-
肿瘤微环境是肿瘤细胞生长的环境,它由肿瘤细胞、免疫细胞、间质细胞和细胞外基质构成,肿瘤微环境由各种各样的细胞、细胞外间质、大量的成纤维细胞以及各种因子组成,其成分较为复杂,近年来随着更多的研究表明,肿瘤微环境与肿瘤耐药性以及在化疗治疗中的作用有着很重要的影响,影响肿瘤微环境治疗耐药的因素很多,不同的影响因素对其产生的作用相同。本文将就其在药物治疗耐药中的作用与其相关影响因素进行简单地探讨与总结。
肿瘤微环境在药物治疗耐药中的作用及其影响因素
-
-
[1] 何林燕, 杨翠霞, 王文涓, 等. 肿瘤相关巨噬细胞诱导乳腺癌耐药的实验研究[J]. 检验医学, 2014, 29(9): 903. doi: 10.3969/j.issn.1673-8640.2014.09.008 [2] YANG C, HE L, HE P, et al. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway[J]. Med Oncol, 2015, 32(2): 352. [3] IRELAND L, SANTOS A, AHMED MS, et al. Chemoresistance in pancreatic cancer is driven by stroma-derived insulin-like growth factors[J]. Cancer Res, 2016, 76(23): 6851. doi: 10.1158/0008-5472.CAN-16-1201 [4] MENG F, HENSON R, PATEL T. Chemotherapeutic stress selectively activates NF-κ B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells[J]. Am J Physiol Cell Physiol, 2007, 293(2): C749. doi: 10.1152/ajpcell.00537.2006 [5] DOBBS JL, SHIN D, KRISHNAMURTHY S, et al. Confocal fluorescence microscopy to evaluate changes in adipocytes in the tumor microenvironment associated with invasive ductal carcinoma and ductal carcinoma in situ[J]. Int J Cancer, 2016, 139(5): 1140. doi: 10.1002/ijc.30160 [6] SUN Y, ZHU D, CHEN F, et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment[J]. Oncogene, 2016, 35(33): 4321. doi: 10.1038/onc.2015.494 [7] WEIGELT B, LO AT, PARK CC, et al. HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment[J]. Breast Cancer Res Treat, 2010, 122(1): 35. doi: 10.1007/s10549-009-0502-2 [8] 魏慧君, 郭丽丽, 李林, 等. Warburg效应及其对肿瘤转移的影响[J]. 中国肺癌杂志, 2015, 18(3): 179. [9] KUMAR S, VAIDYA M. Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27[J]. Mol Cell Biochem, 2016, 415(1/2): 29. [10] ZHANG P, ZHOU H, LU K, , et al. Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer[J]. Onco Targets Ther, 2018, 11(1): 291. [11] OGATA-KAWATA H, IZUMIYA M, KURIOKA D, et al. Circulating exosomal microRNAs as biomarkers of colon cancer[J]. PLoS One, 2014, 9(4): e92921. doi: 10.1371/journal.pone.0092921 [12] NUSRAT O, BELOTTE J, FLETCHER NM, et al. The role of angiogenesis in the persistence of chemoresistance in epithelial ovarian cancer[J]. Reprod Sci, 2016, 23(11): 1484. doi: 10.1177/1933719116645191 [13] ZHANG L, LV Z, XU J, et al. MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway[J]. FEBS J, 2018, 285(7): 1359. doi: 10.1111/febs.14416 [14] TU Y, LIU L, ZHAO D, et al. Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2[J]. Sci Rep, 2015, 5(1): 13827. doi: 10.1038/srep13827 [15] VELICEASA D, BIYASHEV D, QIN G, et al. Therapeutic manipulation of angiogenesis with miR-27b[J]. Vasc Cell, 2015, 7: 6. doi: 10.1186/s13221-015-0031-1 [16] 黄庆波. 血管内皮特异性因子DLL4在肾细胞癌肿瘤生长, 侵袭, 血管生成及血行转移中的作用[D]. 兰州: 兰州大学, 2015. [17] BIAN EB, CHEN EF, XU YD, et al. Exosomal lncRNAATB activates astrocytes that promote glioma cell invasion[J]. Int J Oncol, 2019, 54(2): 713. [18] ZHOU Y, XIA L, LIN J, et al. Exosomes in nasopharyngeal carcinoma[J]. J Cancer, 2018, 9(5): 767. doi: 10.7150/jca.22505 [19] LIU L, MENG T, YANG XH, et al. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion[J]. Cancer Biomark, 2018, 22(2): 283. doi: 10.3233/CBM-171011 [20] LIU C, LIU L, CHEN X, et al. LSD1 Stimulates cancer-associated fibroblasts to drive notch3-dependent self-renewal of liver cancer stem-like cells[J]. Cancer Res, 2018, 78(4): 938. doi: 10.1158/0008-5472.CAN-17-1236
点击查看大图
计量
- 文章访问数: 4046
- HTML全文浏览量: 2402
- PDF下载量: 56
- 被引次数: 0